From: Bioanalytical method development and validation for quantification of amivantamab in rat plasma by LC-MS/MS
Time intervals (minutes)
Amivantamab (ng/ml)
SD
% CV
10
46.216
0.731
1.581
20
28.151
0.640
2.275
30
12.117
0.793
6.548
40
6.517
0.587
9.014
50
2.155
0.414
19.209
60
0